✦ LIBER ✦

Clinical Outcome of the ACCORD 12/0405 PRODIGE 2 Randomized Trial in Rectal Cancer

✍ Scribed by Gerard, J.-P.; Azria, D.; Gourgou-Bourgade, S.; Martel-Lafay, I.; Hennequin, C.; Etienne, P.-L.; Vendrely, V.; Francois, E.; de La Roche, G.; Bouche, O.; Mirabel, X.; Denis, B.; Mineur, L.; Berdah, J.-F.; Mahe, M.-A.; Becouarn, Y.; Dupuis, O.; Lledo, G.; Seitz, J.-F.; Bedenne, L.; Juzyna, B.; Conroy, T.

Book ID: 118167183
Publisher: American Society of Clinical Oncology
Year: 2012
Tongue: English
Weight: 183 KB
Volume: 30
Category: Article
ISSN: 0732-183X
DOI: 10.1200/jco.2012.42.8771

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ACCORD12/0405-Prodige 2 Phase III Trial

ACCORD12/0405-Prodige 2 Phase III Trial Neoadjuvant Treatment in Rectal Cancer: Results after 3 Years of Follow-up

✍ J. Gerard; S. Gourgou-Bourgade; D. Azria; I. Martel-Laffay; C. Hennequin; P. Eti 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Comparison of Two Neoadjuvant Chemoradio

Comparison of Two Neoadjuvant Chemoradiotherapy Regimens for Locally Advanced Rectal Cancer: Results of the Phase III Trial ACCORD 12/0405-Prodige 2

✍ Gerard, J.-P.; Azria, D.; Gourgou-Bourgade, S.; Martel-Laffay, I.; Hennequin, C. 📂 Article 📅 2010 🏛 American Society of Clinical Oncology 🌐 English ⚖ 116 KB

Predictive factors of positive circumfer

Predictive factors of positive circumferential resection margin after radiochemotherapy for rectal cancer: The French randomised trial ACCORD12/0405 PRODIGE 2

✍ Anne Rullier; Sophie Gourgou-Bourgade; Marta Jarlier; Frédéric Bibeau; Catherine 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 199 KB

OC-0451 ACCORD 12 TRIAL OF NEOADJUVANT T

OC-0451 ACCORD 12 TRIAL OF NEOADJUVANT TREATMENT IN RECTAL CANCER: CLINICAL RESULTS AT 3 YEARS. ON BEHALF OF PRODIGE GROUP

✍ J.P. Gérard; D. Azria; S. Gourgou-Bourgade 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 118 KB

Results in the elderly with locally adva

Results in the elderly with locally advanced rectal cancer from the ACCOR12/PRODIGE 2 phase III trial: Tolerance and efficacy

✍ François, Eric; Azria, David; Gourgou-Bourgade, Sophie; Jarlier, Marta; Martel-L 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 345 KB

KRAS Mutation Status and Clinical Outcom

KRAS Mutation Status and Clinical Outcome of Preoperative Chemoradiation With Cetuximab in Locally Advanced Rectal Cancer: A Pooled Analysis of 2 Phase II Trials

✍ Sun Young Kim; Eun Kyung Shim; Hyun Yang Yeo; Ji Yeon Baek; Yong Sang Hong; Dae 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 567 KB